251 related articles for article (PubMed ID: 29651819)
1. Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity.
Kim JY; Cho J; Yang HR
J Korean Med Sci; 2018 Apr; 33(16):e122. PubMed ID: 29651819
[TBL] [Abstract][Full Text] [Related]
2. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
[TBL] [Abstract][Full Text] [Related]
3. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X
Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, body composition, and fat distribution in obese children with nonalcoholic fatty liver disease.
Yang HR; Chang EJ
Asia Pac J Clin Nutr; 2016; 25(1):126-33. PubMed ID: 26965771
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
Prokopowicz Z; Malecka-Tendera E; Matusik P
Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
[TBL] [Abstract][Full Text] [Related]
6. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
7. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
8. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
[TBL] [Abstract][Full Text] [Related]
9. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
Mohamed RZ; Jalaludin MY; Anuar Zaini A
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
[TBL] [Abstract][Full Text] [Related]
10. Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.
Amin S; El Amrousy D; Elrifaey S; Gamal R; Hodeib H
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):117-121. PubMed ID: 28991837
[TBL] [Abstract][Full Text] [Related]
11. Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity.
Wang R; Yang F; Qing L; Huang R; Liu Q; Li X
Clin Obes; 2019 Feb; 9(1):e12289. PubMed ID: 30411515
[TBL] [Abstract][Full Text] [Related]
12. Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV.
Greber-Platzer S; Thajer A; Bohn S; Brunert A; Boerner F; Siegfried W; Artlich A; Moeckel A; Waldecker-Krebs H; Pauer S; Holl RW;
BMC Pediatr; 2019 Sep; 19(1):332. PubMed ID: 31514755
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
Liang S; Cheng X; Hu Y; Song R; Li G
Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease.
Xue J; Liang S; Ma J; Xiao Y
BMC Endocr Disord; 2022 Feb; 22(1):49. PubMed ID: 35216556
[TBL] [Abstract][Full Text] [Related]
15. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
Sayın O; Tokgöz Y; Arslan N
J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
[TBL] [Abstract][Full Text] [Related]
16. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study.
Bălănescu A; Bălănescu P; Comănici V; Stan I; Acs B; Prisăcariu L; Brezan F; Ciomârtan T; Gherghina I
Rom J Intern Med; 2018 Mar; 56(1):47-54. PubMed ID: 29080393
[TBL] [Abstract][Full Text] [Related]
18. Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity.
Liu LJ; Kang YR; Xiao YF
World J Pediatr; 2021 Aug; 17(4):394-399. PubMed ID: 34370215
[TBL] [Abstract][Full Text] [Related]
19. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.
Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW
Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.
Torun E; Özgen IT; Gökçe S; Aydın S; Cesur Y
J Clin Res Pediatr Endocrinol; 2014; 6(1):34-9. PubMed ID: 24637308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
